Skip To Main Content
Sahil Patel on Muck Rack

Sahil Patel

Edison
As seen in: CNN, Illumination, Medium, Nature, The Wall Street Journal, Wiley Online Library, MarketWatch, MDPI, Substack, Taylor & Francis Online and
media reporter & executive assistant to @mvpeers sahil@theinformation.com

Get in touch with Sahil

Contact Sahil, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Next-generation chemogenetic inhibition using a brain-permeant non-prescription agent

|
By Sahil Patel, Luiz Silva, Olivia Goff, Amy W. Richardson, Jesse I. Mobbs, Hariprasad Venugopal, David M. Thal, Dimitri M. Kullmann, Steven O. Devenish, Laura V. Ussingkær
| Nature Verified
Abstract Chemogenetics allows the controllable manipulation of brain circuits upon delivery of a selective activating ligand, and has been invaluable in dissecting brain circuits underlying many behaviours. The Gαi/o-coupled designer muscarinic receptor hM4Di is an especially versatile tool for on-demand inhibition, and has proven effective not only in fundamental neuroscience but also as a therapeutic transgene in preclinical models of epilepsy and other CNS disorders.
Open in Who Shared Issue with article?

Attention-deficit/hyperactivity disorder stimulant use is associated with reduced semen volume in reproductive-age men: a multi-center analysis

|
By Jayant Siva, Rishi Jonnalagadda, Nicholas Heller, Andrew Barr, Sahil Patel, Bryan D Naelitz, Scott D. Lundy, Raevti Bole, Sanjay Vallabhaneni
| Nature Verified
Abstract Stimulant medications are increasingly prescribed for attention-deficit/hyperactivity disorder (ADHD) in men of reproductive age, yet their impact on semen quality remains poorly characterized. We aimed to evaluate whether recent stimulant exposure would negatively affect semen parameters in reproductive-age men with ADHD. We performed a multi-center retrospective analysis of 2039 men aged 18–40 years with a diagnosis of ADHD and available semen volume data between 1995–2025.
Open in Who Shared Issue with article?

An Automated CT-derived Marker of Renal Tumor Complexity: The CLARITY Score

|
By Sahil Patel, Rishi Jonnalagadda, Haya T Abusafieh
| medRxiv
The authors have declared no competing interest. This work was supported in part by the Department of Defense under Award Number HT94252310918. Additional funding was provided by Climb 4 Kidney Cancer, a nonprofit organization dedicated to advancing research, education, and advocacy for kidney cancer. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Open in Who Shared Issue with article?
See all 1,837 licensed articles (1,838 Total)